# Eltrombopag/Boceprevir and Eltrombopag/Telaprevir Drug-Drug Interaction Study In Healthy Adult Subjects

> **NCT01657552** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 56 (actual)

## Conditions studied

- Thrombocytopaenia

## Interventions

- **DRUG:** Eltrombopag
- **DRUG:** Boceprevir
- **DRUG:** Telaprevir

## Key facts

- **NCT ID:** NCT01657552
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-08-01
- **Primary completion:** 2012-10-26
- **Final completion:** 2012-10-26
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2017-11-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01657552

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01657552, "Eltrombopag/Boceprevir and Eltrombopag/Telaprevir Drug-Drug Interaction Study In Healthy Adult Subjects". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01657552. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*